BACHETONI ROSSI VACCARI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 3.177
EU - Europa 1.364
AS - Asia 692
AF - Africa 39
SA - Sud America 32
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.308
Nazione #
US - Stati Uniti d'America 3.115
IT - Italia 488
SG - Singapore 286
SE - Svezia 251
IN - India 227
UA - Ucraina 216
FI - Finlandia 147
CN - Cina 144
DE - Germania 84
CA - Canada 53
BG - Bulgaria 49
AR - Argentina 30
GB - Regno Unito 25
IE - Irlanda 24
RU - Federazione Russa 22
ZA - Sudafrica 21
TG - Togo 14
BE - Belgio 10
FR - Francia 10
PL - Polonia 10
MX - Messico 9
RO - Romania 8
HK - Hong Kong 6
IR - Iran 6
DK - Danimarca 5
JP - Giappone 5
ID - Indonesia 4
MK - Macedonia 4
EU - Europa 3
SC - Seychelles 3
AM - Armenia 2
ES - Italia 2
IQ - Iraq 2
NL - Olanda 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CL - Cile 1
IL - Israele 1
KH - Cambogia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
VN - Vietnam 1
Totale 5.308
Città #
Chandler 348
Fairfield 338
Singapore 195
Woodbridge 178
Ashburn 163
Ann Arbor 141
Rome 131
Wilmington 131
Princeton 130
Houston 126
Plano 106
Seattle 103
Jacksonville 90
Beijing 86
Cambridge 82
Boston 80
Santa Clara 67
Dearborn 64
San Paolo di Civitate 54
Sofia 49
Helsinki 48
Lawrence 45
San Diego 44
Millbury 37
Ottawa 36
Fremont 35
Andover 34
Federal 30
Boardman 29
New York 29
Dublin 24
Des Moines 23
Bremen 18
Norwalk 16
Falls Church 15
Lomé 14
Toronto 14
Johannesburg 13
San Mateo 13
Falkenstein 11
Brussels 10
Grafing 8
Milan 8
Moscow 8
Nanjing 8
Radomsko 8
Mexico City 7
Muizenberg 7
Napoli 7
Southend 7
Bologna 6
Hefei 6
Kunming 6
Mannheim 6
Bühl 5
Hong Kong 5
Los Angeles 5
Nanchang 5
Redmond 5
Redwood City 5
Washington 5
Zanjan 5
Bari 4
Jakarta 4
Jinan 4
Laurel 4
Leawood 4
Pisa 4
Augusta 3
Béura Cardezza 3
Guangzhou 3
Hangzhou 3
Nepi 3
Shenyang 3
Siracusa 3
Torino 3
Velletri 3
Anzio 2
Auburn Hills 2
Belgrade 2
Buffalo 2
Caserta 2
Castelnuovo Rangone 2
Catanzaro 2
Cerreto Sannita 2
Cesano Maderno 2
Civitavecchia 2
Ferrara 2
Hebei 2
Henderson 2
Isernia 2
London 2
Lyon 2
Montréal 2
Mosul 2
Nürnberg 2
Panettieri 2
Phoenix 2
Pomezia 2
Pune 2
Totale 3.429
Nome #
MONITORAGGIO DEL LIVELLO EMATICO DI TACROLIMUS: CARATTERISTICHE DEL DOSAGGIO IN IMx 299
ACMIA versus MEIA assay in therapeutical monitoring of Sirolimus 115
Automated intelligent microscopy for the recognition of decoy cells in urine samples of kidney transplant patients 108
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study 94
Role of biomarkers in adult sepsis and their application for a good laboratory practice. A pilot study 81
Conversione a tacrolimus in monosomministrazione giornaliera: monitoraggio dei livelli sierici del farmaco e dei parametri di funzionalità del graft in pazienti trapiantati di rene 79
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. 78
PRESEPSIN AS A POTENTIAL MARKER FOR BACTERIAL INFECTION RELAPSE IN CRITICAL CARE PATIENTS. A PRELIMINARY STUDY 78
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV child-A cirrhosis 77
Diltiazem downregulates IL-12 production by human dendritic cells 76
Anti-Gal production by isolated mononuclear cells from patients with Crohn's disease. 74
Recovery of chronic renal impairment with sirolimus after lung transplantation. 74
Comparison of the first fully automated agarose gel electrophoresis system with the Capillarys electrophoresis method for the identification of monoclonal immunoglobulins 74
Diltiazem affects human dendritic cell maturation 71
Tacrolimus in monosomministrazione giornaliera nel trapianto di rene: monitoraggio dei livelli sierici del farmaco e dei FR di malattia cardiovascolare 71
A POINT-OF-CARE PRESEPSIN ASSAY FOR THE EVALUATION OF SEPSIS IN CRITICAL CARE UNIT PATIENTS. PRELIMINARY STUDY 70
Long-term Glomerular Filtration Rate and Kidney Disease: Improving Global Outcomes Stage Stability After Conversion to Once-Daily Tacrolimus in Kidney Transplant Recipients 69
Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial 68
Alterations in serum anti-a-galactosyl antibodies in patients with chron’s disease and ulcerative colitis 68
Improvement of Graft Function after Conversion to Once Daily Tacrolimus of Stable Kidney Transplant Patients 68
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS : 8 YEARS GRAFT AND PATIENT SURVIVAL 67
Copeptin kinetics in acute ischemic stroke may differ according to revascularization strategies: pilot data 67
HCV cirrhotic patients treated with direct acting antivirals: detection of tubular dysfunction and resolution after viral clearance 67
Improvement of graft function and cardiovascular risk factors after once daily tacrolimus conversion in stable kidney transplant patients 66
Interleukin-2 Profiles Shortly After Tacrolimus Conversion From a Twice-Daily to Once-Daily Regimen 64
Tacrolimus Trough Levels and Level-to-Dose Ratio in Stable Renal Transplant Patients Converted to a Once-Daily Regimen 63
Long-Term Interleukin-2 Assessment After Conversion From a Twice-Daily to Once-Daily Tacrolimus Regimen in Stable Kidney Recipients 62
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 8 YEARS GRAFT AND PATIENT ACTUARIAL SURVIVAL 61
Monitoring of cytokine profile after conversion to once-daily tacrolimus formulation in stable kidney transplantation 61
EVOLUZIONE DELL'IMMUNOSOPPRESSIONE NEL TRAPIANTO CLINICO DI RENE:ESPERIENZA SU 700 CASI 60
The effect of diltiazem, a calcium channel blocker, in asthmatic patients 59
Renal involvement in HCV related cirrhosis evidenced as glomerular and tubular derangement 58
Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient 58
Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation 57
Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection. 55
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in HCV Child-A cirrhosis 55
Kidney diseases 53
Monosodium urate contributes to retinal inflammation and progression of diabetic retinopathy 53
ALPHA-INTERFERON THERAPY IN PATIENTS WITH HEPATITIS INFECTION UNDERGOING ORGAN-TRANSPLANTATION 52
Effect of interferon free antiviral therapy on glomerular and tubular kidney involvement in hepatitis C virus child-A cirrhosis 52
Analysis of T lymphocytes cloned from rejected kidney allograft: high frequency of cytotoxic T cell precursor 51
Alpha Interferon Therapy in patients with virus hepatitis infection undergoing organ transplantation. 50
ALPHA-INTERFERON PLUS THYMOPENTINE IN TREATMENT OF HBV AND OR HDV POSITIVE PATIENTS UNDERGOING LIVER-TRANSPLANT 50
DIAGNOSTIC ACCURACY OF PRESEPSIN FOR PREDICTION OF BACTERIAL INFECTIONS IN CRITICAL CARE PATIENTS 47
LONG-TERM RESULTS IN RECIPIENTS OF MISMATCHED RELATED AND UNRELATED LIVING KIDNEYS IN THE CYCLOSPORIN AGE 47
Expected and observed glomerular filtration rates in kidney transplant patients converted to once daily tacrolimus: 10 years of follow-up 47
Terapia con alpha Interferon nel trapianto d’organo: studio delle attività citotossiche. 45
Assessment of NGAL as an early biomarker of acute kidney injury in adult cardiac surgery patients 45
Glibenclamide dose response in patients with septic shock: Effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport 45
INFLUENCE OF TOTAL LYMPHOID IRRADIATION PLUS CYCLOSPORINE ON KIDNEY GRAFT OUTCOME IN HIGH-RISK PATIENTS 45
Alpha interferon plus timopentine in patients HBV and/or HDV positive before liver transplant. 43
null 43
Clinical relevance of donor-specific IgG determination by FACS analysis in renal transplantation 43
Compartimentalizzazione di linfociti CD4+ CD56+ nell'allotrapianto renale durante la necrosi tubulare o il rigetto. 42
LONG-TERM FOLLOW-UP OF KIDNEY GRAFTS IN HIGH-RISK PATIENTS UNDER TLI AND CSA THERAPY 42
Immunological studies of renal allograft recipients treated with total lymphoid irradiation. 42
Sofferenza tubulare in un paziente con recente trapianto di rene 42
Exocrine and Neuroendocrine serum markers in colon carcinomas 40
Efficacia clinica del monitoraggio C2 di Neoral in allotrapianti di rene 39
Il monitoraggio-C2 di Neoral come parametro predittivo del rischio di rigetto nei trapianti di fegato 39
Immunological diagnosis of rejection in heart transplant recipients 39
EFFETTO DEL SIERO AUTOLOGO SULLA ATTIVITà DEI PAZIENTI SOTTOPOSTI A TRAPIANTO RENALE 39
Monitoraggio terapeutico del Sirolimus su sangue intero mediante cromatografia liquida ad alta pressione con rilevazione a UV 38
Relevance of immunological parameters to detect allograft rejection in heart transplant recipients 38
DIFFERENT PROTOCOLS OF IMMUNOLOGIC MANIPULATION IN KIDNEY AND PANCREAS TRANSPLANTATION: EXPERIENCE IN 50 CASES. 38
IL-10 e PGE2 modulano la capacità immunostimolatoria delle cellule dendritiche. 38
COMPREHENSIVE EVALUATION OF BRAIN DEAD DONORS FOR LIVER TRANSPLANTATION : PERSONAL EXPERIENCE 38
Comparison of three immunosoppressive regimens in high-risk patients: immunologic aspects 38
Downregulation of recipient immunoresponsiveness to donor transplant antigens induced by CD8+CD28- and CD4+CD25+ cells 37
Cellule dendritiche nei trapianti d'organo 37
AUTOMATED URINARY SEDIMENT ANALYSIS IN THE EARLY FOLLOW-UP OF KIDNEY TRANSPLANTED PATIENTS 37
Conversione a Tacrolimus in monosomministrazione giornaliera nel trapianto di rene: follow up ad un anno 37
Cellule dendridiche nei trapianti d'organo 36
AUTOMATED URINE MICROSCOPY IN THE EVALUATION OF KIDNEY DYSFUNCTION AFTER TRANSPLANTATION 36
Cyclosporine in kidney transplantation: monitoring of NK1 and NK15 subsets of natural killer activity and recycling capacity. 35
Diltiazem impairs maturation and function of human dendritic cells 35
Safety conversion to once daily tacrolimus in kidney transplant patients in multidrug treatment: il-2 monitoring and subclinical rejection 34
Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease 34
INFLAMMATORY CYTOKINES PROFILE AFTER ONCE-DAILY TACROLIMUS CONVERSION IN STABLE KIDNEY TRANSPLANT RECIPIENTS 33
GAMMOPATIA MONOCLONALE DI INCERTO SIGNIFICATO (MGUS) DOPO TRAPIANTO DI RENE 32
Diltiazem reduces nitric oxide production by human immune cells 32
Pre-transplant Total lymphoid irradiation (TLI) in kidney allograft 31
Studio immunologico delle cellule immunocompetenti nel sangue periferico e nel trapianto 31
PROPAGATION AND CHARACTERIZATION OF LYMPHOCYTES INFILTRATING RENAL ALLOGRAFTS 30
Studio dell’attività citotossica monocitaria nel trattamento con alpha Interferon di pazienti HBV e/o HDV positivi in attesa di trapianto d’organo 29
LA PREPARAZIONE DEL RICEVENTE AL TRAPIANTO RENALE CLINICO 29
MONITORING OF NK-1 AND NK-15 SUBSETS AND NATURAL-KILLER ACTIVITY IN KIDNEY-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE 29
PHENOTYPIC AND FUNCTIONAL COMPARATIVE ANALYSIS BETWEEN INFILTRATING KIDNEY TRANSPLANT AND PERIPHERAL BLOOD IMMUNOCOMPETENT CELLS AFTER ALLOGRAFT NEPHRECTOMY 29
Diltiazem affects human dendritic cells maturation 28
Enolase specifica neuronale come marker dei tumori neuroendocrini gastrointestinali 28
Eight-year actuarial graft and patient survival of kidney transplants in highly immunized recipients pretreated with total lymphoid irradiation: A single-center experience 28
Metodo analitico HPLC-UV per la determinazione del Sirolimus su sangue intero 28
null 28
Monitoraggio dei farmaci immunosoppressivi 27
Il laboratorio nel monitoraggio del paziente trapiantato 26
PERFORMANCES OF TWO AUTOMATED CA 125 ASSAYS TO ASSESS THE RISK OF OVARIAN MALIGNANCY ALGORITHM(ROMA):CLINICAL EVALUATION 26
EFFICACY OF CYCLOSPORINE TO REDUCE STEROIDS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS BEFORE LUNG TRANSPLANTATION 25
Diltiazem reduces IL-12 production by human dendritic cells 25
The usefulness of TPA and TPS assays in rectal cancer 24
null 24
Totale 5.155
Categoria #
all - tutte 16.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020626 0 0 0 0 0 124 109 95 72 124 67 35
2020/2021397 69 38 12 30 17 51 9 37 44 56 25 9
2021/20221.077 5 62 82 46 147 32 22 106 77 100 161 237
2022/20231.130 232 214 108 133 128 125 9 31 98 6 29 17
2023/2024480 39 65 22 38 41 95 9 26 0 56 36 53
2024/2025342 44 53 61 31 79 74 0 0 0 0 0 0
Totale 5.459